The White House decided to stop moving forward with an executive order that would have shifted control over NIH research grants to political appointees, maintaining the traditional, non-partisan management of scientific funding.
The Supreme Court's refusal to review cases brought by pharmaceutical companies marks a pivotal moment, signaling strong judicial support for continued Medicare price negotiations. This decision effectively blocks the pharmaceutical industry's attempts to derail efforts aimed at lowering drug costs for Medicare recipients, underscoring a shift towards increased government influence in healthcare pricing.
A recent data exposure related to a CMS provider directory, designed to enhance the accuracy of insurer networks, has inadvertently revealed doctors' Social Security numbers.
Due to the ongoing budget deadlock, some hospitals are compelled to stop offering the Medicare hospital-at-home program, which has successfully enabled the treatment of severely ill patients in their own homes.